Abstract
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common neoplasm in the world and it ranks at third place in the list of cancer-related mortality 1, 2 . As HCC is usually asymptomatic in the early stages, it is diagnozed at an advanced stage 3, 4 . Furthermore, for most patients with HCC, surgery is the only curative treatment procedure, because HCC cells have high resistance to chemotherapeutic agents, so treatment options of HCC is very limited 5 . On the other hand, breast cancer is the leading cause of cancer death among women with approximately a million new cases each year 6 . Despite some therapy options such as surgery, chemotherapy, endocrine and radiation therapy in the treatment of breast cancer, several side effects and drug resistance to chemotherapeutic agents are often encountered problems in the course of therapy 7 . Therefore, it is necessary to develop novel approaches and discover new drug candidates that can be used in the treatment of HCC and/or breast cancer.
Mannich bases are synthesized by using a compound containing a reactive hydrogen atom, formaldehyde and a secondary amine in general. This process is known as the Mannich reaction 8 . They have various biological activities such as cytotoxic [9] [10] [11] [12] [13] , anti-cancer 8 , anti-inflammatory 14 , anti-convulsant 15 and antifungal 16, 17 activities. Their cytotoxic activities may be attributed to the a,b-unsaturated ketone, which is available in the chemical structure of the compound or is produced by deamination process in vivo or under simulated conditions in vitro [18] [19] [20] or inhibition of mitochondrial respiration 21, 22 . In the 1920s, Warburg et al. 23 showed that tumour cells produce large quantities of lactic acid from glucose via the glycolytic pathway, even under aerobic conditions. It has been proposed that this so-called ''aerobic glycolysis'' and the consequent export of lactic acid leads to the low extracellular pH (pHe) characteristic of solid tumours. More recent works suggest that other metabolic pathways may also contribute to acid production 24, 25 . Alternatively, the pHe of solid tumours may be independantly regulated in vivo because it is an intrinsic part of the tumour phenotype 26 . A theoretical model has proposed that a low pHe may confer survival and growth advantages for tumour cells at the expense of the surrounding normal cells 27 and in vitro studies have shown that a low pHe favours metastatic behaviour and production of angiogenic factors by human cells 28, 29 . In any case, as the intracellular pH (pHi) is tightly controlled and maintained at neutral or slightly alkaline levels, the low pHe of solid tumours leads to a pH gradient (pHe-pHi) across the plasma membrane, which is the reverse of that found in normal tissue 30 . This reverse or negative pH gradient (D pH) can also have important consequences for the effective delivery of chemotherapeutic drugs from the blood stream to the tumour intracellular space 31 .
A large ÀD pH has been shown to be an important determinant for tumour cell uptake of the anti-cancer drug 5-fluorouracil 32, 33 , and a low pHe favours cellular uptake of other chemotherapeutic drugs that are weak acids, such as chlorambucil, or reduces uptake of weak bases such as mitoxanthrone 6, 34, 35 . The pH of tumours grown s.c. from 30 human tumour xenograft lines in rats were analysed with the use of H þ ionsensitive semi-microelectrodes prior to and following stimulation of tumour cell glycolysis by intravenous infusion of glucose. Without exception, all xenografts responded to the temporary increase in plasma glucose concentration by an accumulation of acidic metabolites, as indicated by a pH reduction to an average value of 6.43 from 6.83. This pH value corresponds to a ten-fold increase in H þ ion activity in tumour tissues as compared to arterial blood 36 . If this is the case, tumour-selective activation of pH-sensitive anti-cancer agents, e.g. alkylating drugs, acid-labile prodrugs or pH-sensitive immunoconjugates may thus be feasible in a wide variety of human cancers.
Hydrazones are a special group of compounds in the Schiff base family among condensation compounds which are synthesized with aldehyde or ketones and amine derivatives in organic chemistry. A great attention has been focused on hydrazones for many researchers because of their various biological activities such as anti-microbial, anti-fungal, anti-inflammatory anti-tubercular, anti-convulsant, anti-tumoural and anti-viral activities 37 . Some polymeric micellar drug delivery systems having hydrazone structure were developed for the delivery of doxorubicin 38 . Hydrazone bond was included as it is cleavable under biologically relevant conditions under slightly acidic conditions (pH ca. 5, typical of the interstitial space of most solid tumours and of the endosomal environment) and is relatively stable under neutral conditions in blood plasma (pH 7.4) 39, 40 . It was expected that this should minimize the release of toxic-free doxorubicin during delivery into tumour tissue and thus decrease side effects and increase the range of doses exploitable in therapy. In another study, the anti-cancer drug, adriamycin is conjugated to the coreforming segments through the hydrazone linkers that are stable under physiological conditions (pH 7.4), but cleavable under acidic intracellular environments in endosomes and lysosomes (pH 5-6) 41 . Considering above mentioned problems and the logic explained, the design and synthesis of hydrazones of some Mannich bases, N,N 0 -bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides, were considered to develop new anti-cancer drug candidates. These compounds were designed as bi-functional alkylating agents and prodrug of Mannich bases, which can provide a,b-unsaturated ketones responsible for the cytotoxicity of them following hydrolysis of hydrazone in acidic environment of cancer cells to produce 2 mols of mono Mannich bases from 1 mol of hydrazone compound first. Then, they undergo deamination to produce a,b-unsaturated ketones which alkylate thiols. Another approach can be deamination of hydrazone first and then reaction of the product generated with cellular thiols by alkylation to produce cytototoxicity.
In addition, as it was previously shown that cytotoxic Mannich bases derived from styryl ketones inhibit mitochondrial respiration in rat liver cells 21, 22 . Inhibition of mitochondrial respiratory chain by the representative compound P7 was also tested in liver homogenate to elucidate the possible mechanisms of actions of the acid-sensitive hydrazones derived from mono Mannich bases.
Experimental

Chemistry
Melting points were determined on an Electrothermal 9100 melting point apparatus (IA9100, Electrothermal, Essex, UK). 
215-218 C, ethanol, 32%), P4m (30 mmol, 4 h, 224-226 C, ethanol, 33%), P5m (20 mmol, 9 h, 196-198 C, methanol-ether, 48%), P6m [42] [43] [44] [45] , NMR data of them was not reported here. In the case of P2m, the mol ratio of ketone, aldehyde and amine was 1:2:1. Acetic acid (99%, 30 ml) was used instead of ethanol. After refluxing 22 h, the solvent was evoporated in vacuo and diethyl ether was added into the residue and the mixture was cooled for one night at 4 C. The precipitated compound was filtered, dried and crystallized from methanol-diethyl ether.
General procedure for the synthesis of hydrazones, N,
A solution of hydrazine hydrate (1 mol ratio) in ethanol was added to a solution of mono Mannich base (2 mol ratio) in ethanolic acetic acid (3% w/v). The mixture was stirred at room temperature for 17-26 h. The precipitated compound was filtered, dried and crystallized from suitable solvent to give the corresponding hydrazone derivatives. The crystals formed were filtered and dried at room temperature. Experimental data of P-series hydrazone compounds, P1-P8 (Scheme 1) are shown in Table 1 . 
Cytotoxic activity assay
Hydrazone compounds, P1-P8 and 5-FU, which was used as positive control compound, were tested against human hepatoma (Huh7) and breast cancer (T47D) cells by NCI-60 SulforhodamineB Assay 46, 47 to identify the compounds with growth-inhibitory activity. Briefly, T47D and Huh7 cells (5000 or 10 000) were inoculated into 96-well plates in 100 ml of standard DMEM medium (Gibco-Invitrogen Corp., Grand Island, NY) 24 h Synthesis of new N,N 0 -bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides 3 prior to treatment with the compounds in increasing concentrations (2.5, 5, 10, 20, 40 mM). After 72 h of treatment, the cell culture medium was discarded and the cells were washed with 1Â PBS (CaCl 2 -, MgCl 2 -free) (Gibco, Invitrogen). Then cells were fixed by gentle addition of 50 ml of ice-cold 10% (w/v) trichloroacetic acid (MERCK) for 60 min at 4 C. After fixation, cells were washed with distilled water and dried in air. The cells were stained using 50 ml of a 0.4% (m/v) of sulforhodamine (SigmaAldrich) in 1% acetic acid solution at room temperature for 10 min. Extra unbound dye was washed five times with 200 ml of 1% acetic acid and air-dried. Sulforhodamine stain, which was bound to cellular proteins, was then solubilized by adding 200 ml of 10 mM Tris-base solution and the absorbance was acquired at 515 nm. Absorbance values of the compounds were normalized to their corresponding controls (DMSO). The IC 50 values were calculated as previously described 48 . The IC 50 values reported are the average of two independent determinations which differed by 510%.
Inhibition of mitochondrial respiration assay
Animals
Experiments were performed on nine adult male Wistar rats (8-week-old), housed in a thermo-neutral environment (22 AE 2 C), on a 12:12 h photoperiod, and provided food and water ad libitum. This investigation was carried out in accordance with the Guide for the Care and Use of Laboratory published by the US National Institute of Health and approved by the institutional animal care commitee (NIH publication No. 85-23, revised 1996). Animals were submitted to a general anaesthesia with isoflurane and the liver was excised and immediately used for the study of mitochondrial respiration.
Study of mitochondrial respiration
Isolation of liver mitochondria. All operations were carried out at 4 C. Liver was finely minced in ice-cold isolation buffer (50 mM Tris, 1 mM EGTA, 70 mM Sucrose, 210 mM Mannitol, pH 7.4 at 4 C) and then homogenized with a Potter-Elvehjem device. The homogenate was centrifuged at 1300g for 3 min at 4 C. The supernatant was centrifuged at 10 000 g for 10 min at 4 C to sediment mitochondria. Finally, the mitochondrial pellet was washed twice and then suspended in 50 mM Tris, 70 mM Sucrose, 210 mM Mannitol, pH 7.4 at 4 C. Protein content was routinely assayed with a Bradford assay using bovine serum albumin (BSA) as a standard 49 . Mitochondria were kept on ice until use.
Measurement of the mitochondrial respiratory chain complexes. Mitochondrial respiration was measured using a Clark-type electrode (Strathkelvin Instruments, Glasgow, UK) as previously reported 50 . Before oxygraph measurement, 3 ml of solution M (100 mM KCl, 50 mM Mops, 1 mM EGTA, 5 mM Kpi, 1 mg/ml BSA) was added to the oxygraph chambers for 10 min then, 0.15 mg of isolated liver mitochondria were introduced with 10 mM glutamate and 2.5 mM malate and the temperature was maintained at 25 C. After that, succinate (25 mM) and adenosine diphosphate were added. Mitochondrial respiration in these conditions allowed determining the activities of the complexes I, II, III and IV (Figure 2 ). After that, the representative Fluor-bearing compound P7 was added at different concentrations.
Results are expressed as mean AE SEM. Statistical analyses were performed using one-way ANOVA followed by a Newman-Keuls post-test. (GraphPad Prism 5, Graph Pad Software, Inc., San Diego, CA). Statistical significance required a p50.05.
Results
In this study, hydrazone compounds P1-P8 bearing a piperidine moiety were synthesized as presented in Scheme 1 for the first time, except compound P1. Experimental data of P-series of compounds are presented in Table 1 . Compounds were obtained with the yield of 9-88%. The chemical structures of newly synthesized compounds were assigned on the basis of their spectroscopic data such as UV, 1 H NMR and 13 C NMR and HRMS. Spectral data are presented at the experimental section. Spectral data of the compounds were in accordance with the chemical structures of the compounds synthesized.
All the synthesized compounds having the chemical structure of N,N 0 -bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides were evaluated against the human hepatoma cells (Huh7) and breast cancer cells (T47D) in terms of cytotoxic activity. The cytotoxicity of the compounds and reference compound 5-FU are listed in Table 2 in terms of the inhibitory potencies (IC 50, mM).
Hydrazone compounds, P1 (4.86 times), P2 (10.08 times), P7 (5.26 times) and P8 (1.07 times, almost equal to 5-FU) had higher cytotoxic potency than the reference compound, 5-FU, against Huh7 cells. Of the compounds synthesized, only P2, a 4-methyl derivative, had more potent cytotoxic activity than 5-FU against T47D cells (1.45 times). The representative cytotoxic compound P7 inhibited the mitochondrial respiration significantly at 144, 264 and 424 mM concentrations dose-dependantly in liver homogenates ( Figure 1) .
ConcentraƟon (μM) of P7 Figure 1 . In vitro effects of increasing concentrations of P7 on rat liver mitochondrial respiratory chain. p50.05 (one-way ANOVA followed by Tukey). 
Discussion
In this study, hydrazone compounds were designed as acidsensitive compounds targeting cancer cells that have lower pH value than corresponding normal tissues. There are three suggested mechanisms of action for the cytotoxicity of designed chemical structures 51, 52 : firstly, hydrazone compounds may undergo deamination to produce N,N 0 -bis(1-arylpropylidene)hydrazine, then interact with cellular thiol to form cytotoxicity. Secondly, hydrazone compound undergoes hydrolysis at the acidic pH of cancer cells to produce 2 mols of mono Mannich bases (Pm-Series) from 1 mol of hydrazone (P-Series) first, then they may undergo deamination to produce biologically active species a,b-unsaturated ketones, which alkylate cellular thiols to produce cytotoxicity. Thirdly, inhibition of mitochondrial respiration by the compounds.
The chemical structures of newly synthesized compounds were assigned on the basis of their spectroscopic data such as UV, 1 H NMR and 13 C NMR and HRMS. Spectral data are presented in the experimental section. Spectral data of the compounds were in accordance with the chemical structures of the compounds synthesized. As an example, compound P1's spectral data can be summarized. When examined, the In the spectrum, the signal observed in d 21.39 ppm belonged to the carbon atoms which were on positions 3 and 5 according to the nitrogen atom of piperidine ring. In HRMS spectrum of compound P1, molecular ion signal which confirmed the structure of P1 was observed in m/z 431.32. M þ 1 signal was in m/z 432.32. The signal that had the highest rate of relative abundance and confirmed that the fragmentation of the molecule occured between the imine groups was in m/z 216. 16 . In UV spectrum of compound P1, the signal which was observed in 303 nm belonged to the chromophor imine group-conjugated phenyl ring. This signal was due to ! Ã electronic transition of imine group.
When the relationships between the cytotoxicity of the compounds and physicochemical parameters tested (Hammett , Hansch and log P, data not shown) were investigated, there were no correlation. Data were analysed by using the bivariate, Pearson correlation method in SPSS for Windows program (IBM, New York, NY). Observed cytotoxicities with P-Series of compounds against cell lines used, may be explained with the optimum deamination ratio of the compounds in cancer cells tested to produce biologically active alkylation centre or interaction with some steps at the electron transport chain in mitochondria. On the other hand, absence of cytotoxicity with some compounds of PSeries may be explained by faster deamination of the compounds than the optimal level in the tested cells, which can cause faster elimination of the active metabolite before reaching their target. Second explanation for the absence of cytotoxicity may be the lack of interaction with the proper receptors for the bioactivity or the production of 1-aryl-3-(3-aryl-4,5-dihydropyrazol-1-yl)propan-1-one, which does not have suitable centre for thiol alkylation. Third, the compounds which dont have cytotoxicity may not have any interaction with electron transport chain in mitochondria.
Previously, it was shown that cytotoxic Mannich bases derived from styryl ketones inhibit mitochondrial respiration in rat liver cells 21, 22 . Accordingly, inhibition of mitochondrial respiratory chain by the compound P7 in this study suggests that inhibition of mitochondrial respiration may be one of the contributing mechanisms to the cytotoxic activity of P7 and the other cytotoxic compounds.
Conclusions
In conclusion, new hydrazones synthesized having a piperidine moiety as potential anti-cancer candidate deserved further structural modification and pharmacological evaluation. We reported here the compounds P2-P8 for the first time with their synthesis, spectral analysis and cytotoxicities of the P-series of compounds against Huh7 and T47D cell lines. Compounds P1 (4.86 times), P2 (10.08 times), P7 (5.26 times) and P8 (1.07 times, almost equal to 5-FU), against Huh7 cell line, compound P2 (1.45 times) against T47D cell line may serve as model candidate compounds for further synthetic designs and studies. Inhibition of the mitochondrial respiration by the representative compound P7 suggests that it may be one of the contributing mechanisms to the cytotoxic activity of the hydrozones.
